TRANSVERSE TIBIAL BONE TRANSFER (TTBT) IN DIABETIC FOOT ULCER (DFU): TECHNICAL ASPECTS, BIOCHEMICAL MECHANISMS, SAFETY AND OUTCOMES OF A NOVEL SURGICAL METHOD
Authors:
- Bartosz ZawadzkiBZBartosz Zawadzki
- Natalia KornackaNKNatalia Kornacka
- Jakub ZwardońJZJakub Zwardoń
- Katarzyna NajaKNKatarzyna Naja
- Miłosz RewekantMRMiłosz Rewekant
- Zuzanna WalczakZWZuzanna Walczak
- Anna ŚwierczekAŚAnna Świerczek
- Aleksander GajkowskiAGAleksander Gajkowski
- Tomasz Adam SzczepanowskiTSTomasz Adam Szczepanowski
- Krzysztof BednarskiKBKrzysztof Bednarski
Open Access
- 30 June 2026
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (2(50))
Abstract
Background. Diabetic foot ulcers (DFUs) affect a substantial proportion of the 589 million adults currently living with diabetes worldwide and remain a leading cause of lower-limb amputation and excess mortality. Despite debridement, offloading, advanced dressings, negative-pressure wound therapy, hyperbaric oxygen, topical growth factors, and revascularisation, recalcitrant ulcers still progress to amputation in approximately 20% of cases, with five-year mortality near 70% among those amputated. Tibial cortex transverse transport (TTT), a derivative of Ilizarov’s distraction osteogenesis principle, has emerged as a regenerative surgical option for advanced DFUs. Methods. We performed a narrative review of literature published between January 2001 and April 2026, identified through PubMed and Google Scholar, addressing surgical technique, biological mechanisms, clinical efficacy, and safety of TTT in DFU. Results. TTT, a small antero-medial tibial corticotomy with slow transverse distraction, elicits a coordinated regenerative response. Mechanistic studies show distraction-induced elevation of proangiogenic mediators and satisfactory outcomes in patients. Clinical data, including a meta-analysis, a multicentre cohort and other small studies, indicate wound healing rates of approximately 95%, limb salvage rates exceeding 95%, and recurrence rates near 3% during two-year follow-up. Significant improvements in ankle-brachial index, dorsal foot temperature, pain scores, and quality of life are consistently reported. Complications are manageable: risks of approximately 2% for tibial fracture and 8% for pin-site infection. Conclusions. TTT is a mechanistically rich, clinically effective, and reasonably safe option for advanced DFUs. Adequately powered multicentre randomised trials comparing TTT with contemporary best practice are needed to define its definitive role.Keywords
This publication has 31 references indexed in Scilit:
- 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050The Lancet Diabetes & Endocrinology, 2025
- Bone transport induces the release of factors with multi-tissue regenerative potential for diabetic wound healing in rats and patientsCell Reports Medicine, 2024
- Effect of tibial cortex transverse transport in patients with recalcitrant diabetic foot ulcers: A prospective multicenter cohort studyJournal of Orthopaedic Translation, 2022
- Modified tibial transverse transport technique for the treatment of ischemic diabetic foot ulcer in patients with type 2 diabetesJournal of Orthopaedic Translation, 2021
- Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic reviewDiabetes/Metabolism Research and Reviews, 2020
- A Unique Collateral Artery Development Program Promotes Neonatal Heart RegenerationCell, 2019
- The function of vascular endothelial growth factorBioFactors, 2009
- High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale studyDiabetologia, 2006
- Angiogenesis and antiangiogenic therapy in hepatocellular carcinomaCancer Letters, 2006
- Classification of diabetic foot woundsThe Journal of Foot and Ankle Surgery, 1996